175 related articles for article (PubMed ID: 23504322)
1. Reduction of the ST6 β-galactosamide α-2,6-sialyltransferase 1 (ST6GAL1)-catalyzed sialylation of nectin-like molecule 2/cell adhesion molecule 1 and enhancement of ErbB2/ErbB3 signaling by microRNA-199a.
Minami A; Shimono Y; Mizutani K; Nobutani K; Momose K; Azuma T; Takai Y
J Biol Chem; 2013 Apr; 288(17):11845-53. PubMed ID: 23504322
[TBL] [Abstract][Full Text] [Related]
2. miR-214 and hypoxia down-regulate Necl-2/CADM1 and enhance ErbB2/ErbB3 signaling.
Momose K; Minami A; Shimono Y; Mizutani K; Nobutani K; Azuma T; Takai Y
Genes Cells; 2013 Mar; 18(3):195-202. PubMed ID: 23301758
[TBL] [Abstract][Full Text] [Related]
3. Silencing of ErbB3/ErbB2 signaling by immunoglobulin-like Necl-2.
Kawano S; Ikeda W; Kishimoto M; Ogita H; Takai Y
J Biol Chem; 2009 Aug; 284(35):23793-805. PubMed ID: 19561085
[TBL] [Abstract][Full Text] [Related]
4. Interaction of nectin-like molecule 2 with integrin alpha6beta4 and inhibition of disassembly of integrin alpha6beta4 from hemidesmosomes.
Mizutani K; Kawano S; Minami A; Waseda M; Ikeda W; Takai Y
J Biol Chem; 2011 Oct; 286(42):36667-76. PubMed ID: 21880726
[TBL] [Abstract][Full Text] [Related]
5. Interaction of Necl-4/CADM4 with ErbB3 and integrin α6 β4 and inhibition of ErbB2/ErbB3 signaling and hemidesmosome disassembly.
Sugiyama H; Mizutani K; Kurita S; Okimoto N; Shimono Y; Takai Y
Genes Cells; 2013 Jun; 18(6):519-28. PubMed ID: 23611113
[TBL] [Abstract][Full Text] [Related]
6. Nectin-like molecule-4/cell adhesion molecule 4 inhibits the ligand-induced dimerization of ErbB3 with ErbB2.
Mizutani K; Kedashiro S; Maruoka M; Ueda Y; Takai Y
Sci Rep; 2017 Sep; 7(1):11375. PubMed ID: 28900130
[TBL] [Abstract][Full Text] [Related]
7. Necl-2/CADM1 interacts with ErbB4 and regulates its activity in GABAergic neurons.
Yamada A; Inoue E; Deguchi-Tawarada M; Matsui C; Togawa A; Nakatani T; Ono Y; Takai Y
Mol Cell Neurosci; 2013 Sep; 56():234-43. PubMed ID: 23769722
[TBL] [Abstract][Full Text] [Related]
8. Heregulin negatively regulates transcription of ErbB2/3 receptors via an AKT-mediated pathway.
Awasthi S; Hamburger AW
J Cell Physiol; 2014 Nov; 229(11):1831-41. PubMed ID: 24692179
[TBL] [Abstract][Full Text] [Related]
9. Reactive oxygen species regulate ERBB2 and ERBB3 expression via miR-199a/125b and DNA methylation.
He J; Xu Q; Jing Y; Agani F; Qian X; Carpenter R; Li Q; Wang XR; Peiper SS; Lu Z; Liu LZ; Jiang BH
EMBO Rep; 2012 Dec; 13(12):1116-22. PubMed ID: 23146892
[TBL] [Abstract][Full Text] [Related]
10. Significance of integrin αvβ5 and erbB3 in enhanced cell migration and liver metastasis of colon carcinomas stimulated by hepatocyte-derived heregulin.
Yoshioka T; Nishikawa Y; Ito R; Kawamata M; Doi Y; Yamamoto Y; Yoshida M; Omori Y; Kotanagi H; Masuko T; Enomoto K
Cancer Sci; 2010 Sep; 101(9):2011-8. PubMed ID: 20626753
[TBL] [Abstract][Full Text] [Related]
11. Functional cooperation of miR-125a, miR-125b, and miR-205 in entinostat-induced downregulation of erbB2/erbB3 and apoptosis in breast cancer cells.
Wang S; Huang J; Lyu H; Lee CK; Tan J; Wang J; Liu B
Cell Death Dis; 2013 Mar; 4(3):e556. PubMed ID: 23519125
[TBL] [Abstract][Full Text] [Related]
12. Dual Targeting of ERBB2/ERBB3 for the Treatment of SLC3A2-NRG1-Mediated Lung Cancer.
Shin DH; Jo JY; Han JY
Mol Cancer Ther; 2018 Sep; 17(9):2024-2033. PubMed ID: 29959202
[TBL] [Abstract][Full Text] [Related]
13. A global microRNA screen identifies regulators of the ErbB receptor signaling network.
Bischoff A; Bayerlová M; Strotbek M; Schmid S; Beissbarth T; Olayioye MA
Cell Commun Signal; 2015 Jan; 13():5. PubMed ID: 25630670
[TBL] [Abstract][Full Text] [Related]
14. Interaction of integrin alpha(6)beta(4) with ErbB3 and implication in heregulin-induced ErbB3/ErbB2-mediated DNA synthesis.
Kawano S; Mizutani K; Miyata M; Ikeda W; Takai Y
Genes Cells; 2010 Sep; 15(9):995-1001. PubMed ID: 20695903
[TBL] [Abstract][Full Text] [Related]
15. miR-296-5p suppresses EMT of hepatocellular carcinoma via attenuating NRG1/ERBB2/ERBB3 signaling.
Shi DM; Li LX; Bian XY; Shi XJ; Lu LL; Zhou HX; Pan TJ; Zhou J; Fan J; Wu WZ
J Exp Clin Cancer Res; 2018 Nov; 37(1):294. PubMed ID: 30486894
[TBL] [Abstract][Full Text] [Related]
16. Roles of mitogen-activated protein kinase and phosphoinositide 3'-kinase in ErbB2/ErbB3 coreceptor-mediated heregulin signaling.
Vijapurkar U; Kim MS; Koland JG
Exp Cell Res; 2003 Apr; 284(2):291-302. PubMed ID: 12651161
[TBL] [Abstract][Full Text] [Related]
17. Increased erbB3 promotes erbB2/neu-driven mammary tumor proliferation and co-targeting of erbB2/erbB3 receptors exhibits potent inhibitory effects on breast cancer cells.
Lyu H; Huang J; Edgerton SM; Thor AD; He Z; Liu B
Int J Clin Exp Pathol; 2015; 8(6):6143-56. PubMed ID: 26261492
[TBL] [Abstract][Full Text] [Related]
18. A naturally occurring secreted human ErbB3 receptor isoform inhibits heregulin-stimulated activation of ErbB2, ErbB3, and ErbB4.
Lee H; Akita RW; Sliwkowski MX; Maihle NJ
Cancer Res; 2001 Jun; 61(11):4467-73. PubMed ID: 11389077
[TBL] [Abstract][Full Text] [Related]
19. Loss of Nrdp1 enhances ErbB2/ErbB3-dependent breast tumor cell growth.
Yen L; Cao Z; Wu X; Ingalla ER; Baron C; Young LJ; Gregg JP; Cardiff RD; Borowsky AD; Sweeney C; Carraway KL
Cancer Res; 2006 Dec; 66(23):11279-86. PubMed ID: 17145873
[TBL] [Abstract][Full Text] [Related]
20. Suppression of heregulin β signaling by the single N-glycan deletion mutant of soluble ErbB3 protein.
Takahashi M; Hasegawa Y; Ikeda Y; Wada Y; Tajiri M; Ariki S; Takamiya R; Nishitani C; Araki M; Yamaguchi Y; Taniguchi N; Kuroki Y
J Biol Chem; 2013 Nov; 288(46):32910-21. PubMed ID: 24097984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
